![Jean-Yves Blay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Yves Blay
Director/Board Member at
TRANSGENE
Profile
Jean-Yves Blay currently works at Transgene SA, as Independent Director from 2022 and Centre Léon Bérard Lyon et Rhône-Alpes, as General Director from 2014.
Dr. Blay also formerly worked at Innate Pharma SA, as Independent Member-Supervisory Board from 2017 to 2025, European Organisation for Research & Treatment of Cancer, as President from 2009 to 2012, Académie Nationale de Médecine FCP, as Secretary-Oncology Commission, and UNICANCER, as President from 2019 to 2022.
Dr. Blay received his doctorate degree in 1994 from Université Claude Bernard Lyon 1.
Jean-Yves Blay active positions
| Companies | Position | Start |
|---|---|---|
| TRANSGENE | Director/Board Member | 2022-05-24 |
Centre Léon Bérard Lyon et Rhône-Alpes | Chief Executive Officer | 2013-12-31 |
Former positions of Jean-Yves Blay
| Companies | Position | End |
|---|---|---|
| INNATE PHARMA | Director/Board Member | 2025-05-21 |
UNICANCER
 UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | President | 2021-12-31 |
European Organisation for Research & Treatment of Cancer
 European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | President | 2011-12-31 |
Académie Nationale de Médecine FCP
 Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Corporate Officer/Principal | - |
Training of Jean-Yves Blay
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Université Claude Bernard Lyon 1
 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre Léon Bérard Lyon et Rhône-Alpes | |
European Organisation for Research & Treatment of Cancer
European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | Commercial Services |
Académie Nationale de Médecine FCP
Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Commercial Services |
UNICANCER
UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | Health Services |
- Stock Market
- Insiders
- Jean-Yves Blay
Choose MarketScreener 
